Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Using the geriatric nutritional risk index to predict outcomes in older patients with remnant gastric cancer after gastrectomy: a retrospective multicenter study in Japan.
Matsunaga T, Saito H, Osaki T, Fukuda K, Fukumoto Y, Takahashi S, Taniguchi K, Iwamoto A, Kuroda H, Katano K, Shimizu S, Shishido Y, Miyatani K, Sakamoto T, Fujiwara Y. Matsunaga T, et al. Among authors: iwamoto a. Surg Today. 2024 Apr 23. doi: 10.1007/s00595-024-02850-w. Online ahead of print. Surg Today. 2024. PMID: 38652300
Impact of geriatric nutritional risk index on outcomes after gastrectomy in elderly patients with gastric cancer: a retrospective multicenter study in Japan.
Matsunaga T, Saito H, Osaki T, Takahashi S, Iwamoto A, Fukuda K, Taniguchi K, Kuroda H, Takeuchi T, Sugamura K, Sumi K, Katano K, Shishido Y, Miyatani K, Fujiwara Y. Matsunaga T, et al. Among authors: iwamoto a. BMC Cancer. 2022 May 12;22(1):540. doi: 10.1186/s12885-022-09638-6. BMC Cancer. 2022. PMID: 35549906 Free PMC article.
The prognostic impact of the lymphocyte-to-C-reactive protein ratio in patients with unresectable or recurrent advanced gastric cancer treated with first- and second-line treatment.
Matsunaga T, Saito H, Fukumoto Y, Kuroda H, Taniguchi K, Takahashi S, Osaki T, Iwamoto A, Fukuda K, Shimizu S, Shishido Y, Miyatani K, Fujiwara Y. Matsunaga T, et al. Among authors: iwamoto a. Surg Today. 2023 Aug;53(8):940-948. doi: 10.1007/s00595-022-02638-w. Epub 2023 Jan 3. Surg Today. 2023. PMID: 36595075
CA19-9 in combination with P-CRP as a predictive marker of immune-related adverse events in patients with recurrent or unresectable advanced gastric cancer treated with nivolumab.
Matsunaga T, Saito H, Kuroda H, Osaki T, Takahashi S, Iwamoto A, Fukumoto Y, Taniguchi K, Fukuda K, Miyauchi W, Shishido Y, Miyatani K, Fujiwara Y. Matsunaga T, et al. Among authors: iwamoto a. BMC Cancer. 2022 Apr 15;22(1):418. doi: 10.1186/s12885-022-09482-8. BMC Cancer. 2022. PMID: 35428212 Free PMC article.
516 results